Compounds > amoxicillin-potassium-clavulanate-combination

amoxicillin-potassium-clavulanate-combination and flomoxef

amoxicillin-potassium-clavulanate-combination has been researched along with flomoxef* in 1 studies

Other Studies

1 other study(ies) available for amoxicillin-potassium-clavulanate-combination and flomoxef

Article	Year
Early-onset septicemia due to CMY-2-producing Escherichia coli in a woman with blunt abdominal trauma. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2009, Volume: 42, Issue:5 Escherichia coli remains one of the most common etiologies of secondary peritonitis. CMY-2 is the most prevalent AmpC enzyme identified in nosocomial E. coli isolates causing bacteremia in Taiwan. This report is of a patient who underwent surgery for intestinal perforations due to blunt abdominal trauma and developed unexpected CMY-2-producing E. coli septicemia in the early postoperative period. The AmpC-type CMY-2 enzyme might partially contribute to the poor response to antimicrobial therapy of amoxicillin-clavulanic acid or flomoxef. Late changes in antibiotic therapy to an appropriate regimen of cefpirome based on the culture results did not result in a positive outcome and the patient died. Whether selection of an anti-AmpC regimen is appropriate as first-line treatment for traumatic abdomen-associated septicemia should be an area of further investigation in Taiwan. Topics: Abdominal Injuries; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Sepsis; Taiwan	2009

Article

Year

Early-onset septicemia due to CMY-2-producing Escherichia coli in a woman with blunt abdominal trauma.

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2009, Volume: 42, Issue:5

Escherichia coli remains one of the most common etiologies of secondary peritonitis. CMY-2 is the most prevalent AmpC enzyme identified in nosocomial E. coli isolates causing bacteremia in Taiwan. This report is of a patient who underwent surgery for intestinal perforations due to blunt abdominal trauma and developed unexpected CMY-2-producing E. coli septicemia in the early postoperative period. The AmpC-type CMY-2 enzyme might partially contribute to the poor response to antimicrobial therapy of amoxicillin-clavulanic acid or flomoxef. Late changes in antibiotic therapy to an appropriate regimen of cefpirome based on the culture results did not result in a positive outcome and the patient died. Whether selection of an anti-AmpC regimen is appropriate as first-line treatment for traumatic abdomen-associated septicemia should be an area of further investigation in Taiwan.

Topics: Abdominal Injuries; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Sepsis; Taiwan

2009